Generics Bulletin is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Launches US Advair Rival, Wixela Inhub, At A 70% Discount

Executive Summary

Mylan has launched its Wixela Inhub rival to GSK’s Advair Diskus at a 70% discount to the brand price.

Advertisement

Related Content

Glenmark Plans To Spin Out A US-Based ‘Innovation’ Business – And May Pull The Plug On Advair
Mylan Gears Up To Launch US Advair Rival This Month
Mylan’s Nod For US Advair Rival Puts It A Year Ahead Of The Pack
Mylan Draws Hope From FDA’s Fluticasone Labelling Update

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

GB140074

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel